Division of Rhinology and Sinus Surgery, Oregon Sinus Center, Oregon Health & Science University, Portland, OR.
Division of Rhinology and Sinus Surgery, Department of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston, SC.
Int Forum Allergy Rhinol. 2023 Mar;13(3):216-229. doi: 10.1002/alr.23070. Epub 2022 Aug 23.
Productivity loss and activity limitations due to chronic rhinosinusitis (CRS) are known to contribute to the significant economic and personal burden of disease. The purpose of this study was to assess productivity and activity impairment before and after endoscopic sinus surgery (ESS) for medically refractory CRS.
This investigation was a prospective, multi-institutional, observational cohort study. Patients diagnosed with medically refractory CRS completed the Work Productivity and Activity Impairment-Specific Health Problem (WPAI-SHP) questionnaire before surgery and approximately 6 months after the procedure. Factors associated with minimal clinical important differences (MCIDs) for productivity and activity impairment were identified.
A total of 279 study participants were screened for inclusion, of whom 176 (63.1%) with postoperative follow-up were included in the final cohort. Preoperative productivity and activity impairment were observed in 63.2% and 69.8% of the patients, respectively. Among these patients, postoperative improvement equaling at least 1 MCID was reported in both productivity (76.1%) and activity (76.4%) impairments. Multivariate regression identified sphenoidotomy (odds ratio [OR], 4.18; 95% confidence interval [CI], 1.03-17.02) as the only factor associated with increased likelihood of productivity improvement, whereas septoplasty during ESS (OR, 8.45; 95% CI, 2.33-30.68) and migraine (OR, 0.35; 95% CI, 0.12-0.96) were associated with differential odds of activity improvement.
CRS is associated with a substantial burden on productivity and activity that significantly improves after treatment with ESS. These data may facilitate improved patient counseling and shared decision-making regarding surgical management for CRS.
已知慢性鼻-鼻窦炎(CRS)导致的生产力损失和活动受限是疾病带来的重大经济和个人负担的原因。本研究的目的是评估药物难治性 CRS 患者内镜鼻窦手术(ESS)前后的生产力和活动受损情况。
这是一项前瞻性、多机构、观察性队列研究。被诊断为药物难治性 CRS 的患者在手术前和手术后大约 6 个月完成了工作生产力和活动障碍-特定健康问题(WPAI-SHP)问卷。确定了与生产力和活动障碍的最小临床重要差异(MCID)相关的因素。
共有 279 名研究参与者被筛选纳入,其中 176 名(63.1%)有术后随访被纳入最终队列。分别有 63.2%和 69.8%的患者术前存在生产力和活动障碍。在这些患者中,报告了术后改善至少等于 1 MCID 的患者在生产力(76.1%)和活动(76.4%)障碍方面都有所改善。多变量回归确定了蝶窦切开术(优势比[OR],4.18;95%置信区间[CI],1.03-17.02)是与生产力改善可能性增加相关的唯一因素,而 ESS 期间的鼻中隔成形术(OR,8.45;95% CI,2.33-30.68)和偏头痛(OR,0.35;95% CI,0.12-0.96)与活动改善的差异可能性相关。
CRS 与生产力和活动显著受损相关,ESS 治疗后显著改善。这些数据可能有助于改善患者咨询和关于 CRS 手术管理的共同决策。